Agilent Technologies, Inc.
Every calculator, already run for A
Open the full toolkit →You have the numbers on A. Get the argument.
A written report on which of these readings actually decide the outcome for Agilent Technologies, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
23 analysts covering AAnalyst Price Target Disagreement for Agilent Technologies, Inc.
Wall Street's bull case implies +21% from the current price; the bear case implies -1%. Analysts are relatively aligned on A's range.
Ownership & short interest
Insider Trading Activity for A
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Agilent Technologies, Inc.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations…
A — frequently asked
Is A a buy right now?
Wall Street's consensus rating on Agilent Technologies, Inc. is Buy across 23 analysts, with a mean price target of $174.95 (+12% vs. the current $156.47). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is A overvalued?
A trades at 30.9x trailing earnings, against a DCF fair value of $67 per share. The current price implies 18% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is A's next earnings date?
Agilent Technologies, Inc. is next scheduled to report earnings around Nov 25, 2026. A full A research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Agilent Technologies, Inc.?
Analysts covering Agilent Technologies, Inc. (A) range from a bear-case target of $155.00 to a bull-case high of $190.00, with a mean consensus target of $174.95 across 21 analysts. The spread of $35.00 (22% of the current price) indicates moderate disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Agilent Technologies, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Agilent Technologies, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full A research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Agilent Technologies, Inc., in minutes. 3 free reports included with every account — no credit card required.